ArticleScientific reports2025

Isoniazid preventive therapy modulates Mycobacterium tuberculosis-specific T-cell responses in individuals with latent tuberculosis and type 2 diabetes.

Phillip Ssekamatte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.